Blood Pressure Flashcards
A 60-year-old female presents to the emergency department after developing confusion with severe headache and nausea. Shortly after arrival she has a generalized tonic-clonic seizure lasting less than 30 seconds. She has a blood pressure of 220/130 mm Hg, a pulse rate of 85 beats/min, and an oxygen saturation of 98% on room air. Cardiac enzymes are negative. Noncontrast CT of the head is negative for hemorrhage and contrast CT of the chest and abdomen reveals no aortic dissection. Based on guidelines from the American Heart Association, the patient’s blood pressure is lowered by approximately 20% during the first hour of treatment.
Assuming the patient remains clinically stable, the goal over the next 2–6 hours is to lower her blood pressure to:
160/100
This patient is having a hypertensive emergency with encephalopathy and the goal is to lower her blood pressure by no more than 25% in the first hour. Over the next 2–6 hours, her blood pressure should be lowered to 160/100 mm Hg. After that level is achieved, her blood pressure may be cautiously lowered to normal over the ensuing 24–48 hours. Lowering blood pressure too aggressively can lead to cerebral ischemia and should be avoided.
A 70-year-old male with a past medical history significant for long-standing diabetes mellitus and hypertension presents with a stroke. CT of the head shows mild atrophy, with no acute bleeding.
In the first 24 hours after his stroke, starting treatment to control his blood pressure is recommended if it reaches what threshold level? (check one)
- 150/90 mm Hg
- 160/100 mm Hg
- 180/100 mm Hg
- 200/110 mm Hg
- 220/120 mm Hg
220/120
Elevated blood pressure may have a protective effect in the initial period after an ischemic stroke, and studies have shown adverse outcomes when it is lowered in the acute period. Blood pressure usually will spontaneously decrease without treatment in the first several hours after presentation, and antihypertensive treatment should not be started in the first 24 hours after an acute stroke unless blood pressure exceeds 220/120 mm Hg, or treatment is warranted because of another medical condition such as acute myocardial infarction. Tighter blood pressure control becomes more important after the first 24 hours.
An otherwise healthy 55-year-old female is diagnosed with hypertension, based on multiple measurements of systolic blood pressures ranging from 142 to 148 mm Hg and diastolic blood pressures in the range of 90–96 mm Hg over the past 4 months. You are now discussing medication options. The patient exercises regularly and conscientiously adheres to a very healthy diet, and has a BMI of 20 kg/m2. She is concerned with the potential long-term adverse side effects of medication in general, and asks if any agents have potential advantages.
Which one of the following medications has been shown to reduce bone loss and may reduce her risk of future hip fractures? (check one)
- Amlodipine (Norvasc)
- Hydrochlorothiazide
- Lisinopril (Prinivil, Zestril)
- Losartan (Cozaar)
- Metoprolol (Lopressor, Toprol-XL)
Hydrochlorothiazide
Thiazide diuretics have proven efficacy in the treatment of hypertension in all age groups and sexes. When used as antihypertensive agents, the reduction in adverse cardiovascular outcomes equals that of a-blockers, calcium channel blockers, and ACE inhibitors. Successful thiazide treatment of hypertension is especially effective in preventing heart failure or strokes. Unlike the other options listed, thiazide diuretics have also been shown to slow cortical bone loss in postmenopausal females and to reduce the incidence of osteoporosis and hip fractures in those who take it continuously. This protective beneficial side effect disappears within 4 months following discontinuation of thiazide therapy. As with all medications there are potential disadvantages of thiazide use, including excessive urinary losses of potassium and sodium and possible increases in serum glucose levels.
A 75-year-old female with no significant past medical history presents to your office with a recent onset of postural dizziness and lightheadedness. An evaluation reveals a diagnosis of orthostatic hypotension with no underlying etiology identified. After an unsuccessful trial of managing her symptoms with nonpharmacologic measures, she returns to discuss additional treatment options.
Which one of the following oral medications would be the preferred initial treatment? (check one)
Atomoxetine (Strattera)
Clonidine
Midodrine
Phenylephrine
Pyridostigmine (Mestinon)
Midodrine
Treatment of orthostatic hypotension begins with identifying and addressing the underlying cause(s) when possible. This may include correcting a reversible medical condition or discontinuing an offending medication. Nonpharmacologic measures should be initiated next and typically include increasing fluid and sodium intake, improving physical fitness, wearing compression garments, and avoiding hot and humid environments. When additional treatment is needed, first-line medication options include midodrine or droxidopa, which act by increasing peripheral vascular resistance. Off-label use of atomoxetine or pyridostigmine may be considered as adjunct therapy but these medications are not part of the initial management. The α-antagonist clonidine typically causes a decrease in blood pressure through central action on the sympathetic nervous system. In patients with autonomic dysfunction, however, clonidine can increase venous return without a blood pressure–lowering effect and therefore improve orthostatic hypotension, but it should only be considered a supplementary treatment. The α-sympathomimetic medication phenylephrine may also be considered as a second-line option, but it is not part of the initial management of orthostatic hypotension.
A 54-year-old male sees you for a 6-month follow-up visit for hypertension. He feels well, but despite the fact that he takes his medications faithfully, his blood pressure averages 150/90 mm Hg. He has had an intensive workup for hypertension in the recent past, with normal repeat laboratory results, including a CBC, serum creatinine, an electrolyte panel, and a urinalysis. His medications include chlorthalidone, 12.5 mg daily; carvedilol (Coreg), 25 mg twice daily; amlodipine (Norvasc), 10 mg daily; and lisinopril (Prinivil, Zestril), 40 mg daily. He has been intolerant to clonidine (Catapres) in the past.
Which one of the following medication changes would be most reasonable? (check one)
Adding isosorbide mononitrate (Imdur)
Adding spironolactone (Aldactone)
Substituting furosemide (Lasix) for chlorthalidone
Substituting losartan (Cozaar) for lisinopril
Adding spironolactone (Aldactone)
Spironolactone is now recommended for treating resistant hypertension, even when hyperaldosteronism is not present. A longer-acting diuretic such as chlorthalidone is also recommended for treating hypertension, particularly in resistant cases with normal renal function. There is no benefit to switching from an ACE inhibitor to an ARB. Nitrates have some effect on blood pressure but are recommended only for patients with coronary artery disease.
For several years, a hypertensive 65-year-old female has been treated with hydrochlorothiazide, 25 mg/day; atenolol (Tenormin), 100 mg/day; and hydralazine, 50 mg 4 times/day. Her blood pressure has been well controlled on this regimen. Over the past 2 months she has experienced malaise, along with diffuse joint pains that involve symmetric sites in the fingers, hands, elbows, and knees. A pleural friction rub is noted on examination. Laboratory testing shows that the patient has mild anemia and leukopenia, with a negative rheumatoid factor and a positive antinuclear antibody (ANA) titer of 1:640.
Which one of the following would be the most appropriate INITIAL step? (check one)
Replace hydrochlorothiazide with furosemide (Lasix)
Discontinue hydralazine
Start prednisone, 40 mg/day orally
Start hydroxychloroquine (Plaquenil), 400 mg/day
Order renal function studies and anticipate that a renal biopsy will be needed
Discontinue hydralazine
There are many drugs that can induce a syndrome resembling systemic lupus erythematosus, but the most common offenders are antiarrhythmics such as procainamide. Hydralazine is also a common cause. There is a genetic predisposition for this drug-induced lupus, determined by drug acetylation rates. Polyarthritis and pleuropericarditis occur in half of patients, but CNS or renal involvement is rare. While all patients with this condition have positive antinuclear antibody titers and most have antibodies to histones, antibodies to double-stranded DNA and decreased complement levels are rare, which distinguishes drug-induced lupus from idiopathic lupus.
The best initial management for drug-induced lupus is to withdraw the drug, and most patients will improve in a few weeks. For those with severe symptoms, a short course of corticosteroids is indicated. Once the offending drug is discontinued, symptoms seldom last beyond 6 months.
You suspect orthostatic hypotension in an elderly male who reports “dizziness” when standing up, and you decide to obtain recumbent and standing blood pressure measurements. After the patient rests in a supine position for 5 minutes, you measure his baseline blood pressure and then ask him to stand, which he does without a problem.
For how long should his blood pressure be periodically measured before considering the test complete? (check one)
30 seconds
60 seconds
90 seconds
3 minutes
5 minutes
3 minutes
Orthostatic hypotension is defined as a documented drop in blood pressure of at least 20 mm Hg systolic or 10 mm Hg diastolic that occurs within 3 minutes of standing. When symptomatic it is often described as lightheadedness or dizziness upon standing. Etiologies to consider include iatrogenic, neurologic, cardiac, and environmental causes, plus many others alone or in combination. Since orthostatic hypotension may result in syncope, leading to falls and substantial injury, identifying it and taking corrective steps can produce a significant benefit.
An 11-year-old male is brought to your clinic for follow-up after a recent well child visit revealed elevated blood pressure. The parents have restricted his intake of sodium and fatty foods during the last several weeks. His blood pressure today is 140/92 mm Hg, which is similar to the reading at his last visit. The parents checked the child’s blood pressure with a home unit several times and found it consistently to be in the 130s systolic and low 80s diastolic. The child had a normal birth history and has no known chronic medical conditions. Both of his parents and his two younger siblings are healthy. He is at the 75th percentile for both height and weight with a BMI in the normal range. He eats a balanced diet and is active.
What should be the next step for this patient?
(check one)
Reassurance that this is likely white-coat hypertension
A goal weight loss of at least 5 lb
Evaluation for causes of secondary hypertension
Hydrochlorothiazide
Lisinopril (Prinivil, Zestril)
Evaluation for causes of secondary hypertension
The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents defines hypertension in children as a systolic or diastolic blood pressure above the 95th percentile for the patient’s sex, age, and height on several different readings. Although it is appropriate to have this finding confirmed in the outpatient setting, 130 mm Hg is still at the 99th percentile for systolic blood pressures in this patient. Hypertension in a patient this young should prompt a search for secondary causes, which are more common in young hypertensive patients than in adults with hypertension. The recommended workup includes blood and urine testing, as well as renal ultrasonography. An evaluation for end-organ damage is also recommended, including retinal evaluation and echocardiography.
Which one of the following is a preferred first-line agent for managing hypertension in patients with stable coronary artery disease? (check one)
A thiazide diuretic
An angiotensin receptor blocker
A β-blocker
A long-acting calcium channel blocker
A long-acting nitrate
A β-blocker
American Heart Association guidelines recommend treating hypertension in patients with stable heart failure with ACE inhibitors and/or β-blockers. Other agents, such as thiazide diuretics or calcium channel blockers, can be added if needed to achieve blood pressure goals (SOR B). β-Blockers with intrinsic sympathomimetic activity should be avoided, as they increase myocardial oxygen demand.
While thiazide diuretics are often a first choice for uncomplicated hypertension, this is not the case for patients with coronary artery disease. Long-acting calcium channel blockers may be used in patients who do not tolerate β-blockers, but short-acting calcium channel blockers should be avoided because they increase mortality. ACE inhibitors are recommended as antihypertensive agents in patients already on β-blocker therapy (especially following myocardial infarction), in diabetics, and in patients with left ventricular dysfunction. Although angiotensin receptor blockers have indications similar to those of ACE inhibitors, the American Heart Association recommends using them only in patients who do not tolerate ACE inhibitors. Long-acting nitrates are used for their anti-anginal properties and have no role in the management of hypertension.
A 48-year-old female presents as a new patient to your office. She has not seen a physician for several years and her medical history is unknown. Her BMI is 24.4 kg/m2 and she is not taking any medication. Her blood pressure is 172/110 mm Hg in the left arm sitting and 176/114 mm Hg in the right arm sitting; her cardiovascular examination is otherwise unremarkable. A baseline metabolic panel reveals a creatinine level of 0.68 mg/dL (N 0.6–1.1) and a potassium level of 3.3 mEq/L (N 3.5–5.5).
If the patient’s hypertension should prove refractory to treatment, which one of the following tests is most likely to reveal the cause of her secondary hypertension?
(check one)
A 24-hour urine catecholamine level
A plasma aldosterone/renin ratio
MRA of the renal arteries
Echocardiography
A sleep study (polysomnography)
A plasma aldosterone/renin ratio
Primary hyperaldosteronism is the most common cause of secondary hypertension in the middle-aged population, and can be diagnosed from a renin/aldosterone ratio. This diagnosis is further suggested by the finding of hypokalemia, which suggests hyperaldosteronism even though it is not present in the majority of cases.
An echocardiogram would help make a diagnosis of coarctation of the aorta, but this is more common in younger patients. Renal MRA may demonstrate renal artery stenosis, but this condition is more common in older patients. Sleep apnea is increasing in prevalence along with the rise in obesity, but it is not suggested by this case. A 24-hour urine catecholamine test is used to diagnose pheochromocytoma, which is not suggested by this patient’s findings. Pheochromocytoma is also less common than aldosteronism (SOR C).
A 55-year-old female comes to your clinic for follow-up of her poorly controlled hypertension. Her medical history also includes type 2 diabetes and worsening obstructive sleep apnea (OSA). Her BMI is 52 kg/m2. Her heart rate is 62 beats/min and regular. Her blood pressure in the clinic today is 160/96 mm Hg, and she reports similar average readings at home. She is asymptomatic and says she has been following lifestyle modifications including a low-salt diet. She also reports that she has been adherent with her current antihypertensive regimen, which includes the following:
Amlodipine (Norvasc), 10 mg daily
Carvedilol (Coreg), 25 mg twice daily
Chlorthalidone, 25 mg daily
Losartan (Cozaar), 100 mg daily
Which one of the following antihypertensive medication changes would benefit both her blood pressure and her OSA? (check one)
Switching chlorthalidone to hydrochlorothiazide, 25 mg daily
Switching carvedilol to an equivalent dosage of metoprolol tartrate (Lopressor)
Switching losartan to an equivalent dosage of an ACE inhibitor
Increasing the current dosage of losartan to 100 mg twice daily
Adding a low dosage of spironolactone (Aldactone) to her current regimen
Adding a low dosage of spironolactone (Aldactone) to her current regimen
Secondary forms of hypertension are common in patients with resistant hypertension, and sleep-disordered breathing is an important cause of resistant hypertension. Multiple studies have shown that excess aldosterone plays a key role in the association between the two. As rates of obesity and obstructive sleep apnea (OSA) have increased, the prevalence of resistant hypertension has also increased. It is estimated that almost 17%–22% of patients with resistant hypertension may have undiagnosed primary hyperaldosteronism. The increased expression of mineralocorticoid receptors in patients with a high BMI contributes to hyperaldosteronism, and blockage of these receptors with medications such as spironolactone has been shown to provide benefit in reducing the severity of OSA as well as hypertension in these patients.
Substituting one thiazide for another does not have a beneficial effect in patients with resistant hypertension. Switching β-blockers in this case is unlikely to have a significant impact on blood pressure and might have an adverse impact, as carvedilol has been shown to have more favorable effects on glycemic control and other components of metabolic syndrome relative to metoprolol tartrate in patients with diabetes. Increasing the angiotensin receptor blocker dosage or substituting an ACE inhibitor will not be as beneficial in controlling this patient’s blood pressure.
An 8-year-old female is brought to your office by her parents for follow-up 6 months after you recommended a DASH diet and 1 hour of physical play daily to address her BMI and blood pressure, which were both greater than the 95th percentile for her age and height. Her mother also has a history of obesity and hypertension. The patient otherwise has an unremarkable past medical history. Although she has lost 1.4 kg (3 lb) her blood pressure remains at 125/77 mm Hg. You diagnose stage 1 hypertension and recommend management with medication.
In addition to a CBC; electrolyte, BUN, and creatinine levels; a urinalysis; and a lipid panel, you recommend (check one)
no further testing
serum or urine catecholamine measurement
renal Doppler ultrasonography
CT angiography of the kidneys
echocardiography
echocardiography
Echocardiography should be performed to assess for cardiac target end-organ damage, such as left ventricular hypertrophy, when medication is being considered in children with hypertension. Evaluation for secondary causes of hypertension is not needed in children >6 years of age with stage 1 hypertension if they are overweight or have a positive family history of hypertension and there are no physical examination findings indicative of a secondary cause. Renal imaging, catecholamine and steroid levels, and renin activity are indicated in children <6 years of age or patients with stage 2 hypertension (≥95th percentile plus 12 mm Hg systolic or diastolic blood pressure or ≥140/90 mm Hg, whichever is lower).
A 32-year-old gravida 2 para 1 with long-standing untreated hypertension presents at 8 weeks gestation for prenatal care. Her physical examination is normal except for a blood pressure of 156/114 mm Hg.
Which one of the following would be most appropriate as initial treatment?
(check one)
Labetalol (Trandate)
Lisinopril (Prinivil, Zestril)
Losartan (Cozaar)
Metoprolol (Lopressor, Toprol-XL)
Nifedipine, immediate release (Procardia)
Labetalol (Trandate)
The drug most often recommended as first-line therapy for hypertension in pregnancy is labetalol. Reports of an association of metoprolol with fetal growth restriction have given rise to the recommendation to avoid its use in pregnancy. Both ACE inhibitors and angiotensin-receptor blockers are contraindicated in pregnancy because of the risk of birth defects and fetal or neonatal renal failure. Immediate-release nifedipine is not recommended due to the risk of hypotension.
According to the 2022 American Academy of Family Physicians clinical practice guideline, treatment to a blood pressure target of <135/85 mm Hg in adults who have hypertension reduces which one of the following? (check one)
All-cause mortality
Cardiovascular mortality
Risk of myocardial infarction
Risk of stroke
Risk of myocardial infarction
The 2022 American Academy of Family Physicians clinical practice guideline recommends treating adults who have hypertension to a standard target of <140/90 mm Hg based on high-quality evidence. Moderate-quality evidence showed that treating adults to a lower blood pressure target of <135/85 mm Hg further reduced the risk of myocardial infarction compared to the standard target, with a number needed to treat of 137 over 3.7 years. There was no benefit in mortality or stroke risk. Of note, treating to a lower target blood pressure does increase the absolute risk of serious adverse events by 3%, with a number needed to harm of 33 over 3.7 years.
A 72-year-old white male has new-onset hypertension with a current blood pressure of 190/110 mm Hg. Which one of the following agents can be used as part of a test for diagnosing renovascular hypertension, but would also increase the risk for azotemia if used for treatment? (check one)
Captopril (Capoten)
Metoprolol (Lopressor)
Clonidine (Catapres)
Furosemide (Lasix)
Amlodipine (Norvasc)
Captopril (Capoten)
ACE inhibitors can significantly worsen renal failure in patients with hypertension caused by renovascular disease. Hyperkalemia is an associated problem. Captopril renography is a useful diagnostic screening test. The other agents are useful for lowering blood pressure but may cause mild creatinine elevations. They do not, however, cause the significant elevations of creatinine seen with ACE inhibitors in cases of significant renovascular disease.